Polymer formulations of CETP inhibitors

Details for Australian Patent Application No. 2007212197 (hide)

Owner Merck & Co., Inc.

Inventors Geers, Sarah; Zhang, Dina; Meyer, Robert F.; Lowinger, Michael; Mckelvey, Craig A.

Agent Spruson & Ferguson

Pub. Number AU-A-2007212197

PCT Pub. Number WO2007/092642

Priority 60/771,782 09.02.06 US

Filing date 9 February 2007

Wipo publication date 16 August 2007

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

Event Publications

7 August 2008 PCT application entered the National Phase

  PCT publication WO2007/092642 Priority application(s): WO2007/092642

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007212201-Multi-arm polymeric conjugates of 7ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers

2007212195-Antibodies that bind PAR-2